CMS Belgium advised Graftys and its shareholders on the deal.Graftys and its shareholders, a Belgian Medtech company specializing in the development and manufacturing of synthetic bone…
Graftys’ Acquisition of Biologics4life

CMS Belgium advised Graftys and its shareholders on the deal.Graftys and its shareholders, a Belgian Medtech company specializing in the development and manufacturing of synthetic bone…